Clearstead Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
|
|||||
|
2025
Q1 | $132K | Sell |
|
|||||
|
2024
Q4 | $117K | Buy |
|
|||||
|
2024
Q3 | $120K | Hold |
|
|||||
|
2024
Q2 | $107K | Buy |
|
|||||
|
2024
Q1 | $98.3K | Sell |
|
|||||
|
2023
Q4 | $107K | Sell |
|
|||||
|
2023
Q3 | $189K | Buy |
|
|||||
|
2023
Q2 | $97K | Hold |
|
|||||
|
2023
Q1 | $83.3K | Hold |
|
|||||
|
2022
Q4 | $104K | Hold |
|
|||||
|
2022
Q3 | $60K | Hold |
|
|||||
|
2022
Q2 | $52K | Hold |
|
|||||
|
2022
Q1 | $56K | Buy |
|
|||||
|
2021
Q4 | $40K | Hold |
|
|||||
|
2021
Q3 | $35K | Hold |
|
|||||
|
2021
Q2 | $71K | Hold |
|
|||||
|
2021
Q1 | $59K | Buy |
|
|||||
|
2020
Q4 | $81K | Hold |
|
|||||
|
2020
Q3 | $71K | Buy |
|